Delisted
Stopped trading. Fund positions aren't valued until we confirm what happened.
RA PHARMACEUTICALS INC
RARX·74933V108·US·Common Stock
RARX (RA PHARMACEUTICALS INC) is held by 0 institutional investors as of Q2 2020.
0
Holders
$0
Total Value
0%
Consensus
13F: Insider & Congress: Updated regularly
No verdict yet — fewer than 2 funds hold RARX.
Top Holders
Checking access…
| Action | ||||||
|---|---|---|---|---|---|---|
Exited | 0(-100.0%) | $527,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $804,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $4.8M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $2.3M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $126,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $1.9M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $843,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $2.3M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $2.5M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $30.6M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $903,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $2.4M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $1.5M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $69.1M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $936,291 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $345,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $100.5M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $1,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $14.9M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $4.8M | 0.0% | — | 0 |
Showing 1-20 of 72
1 / 4
RARXRA PHARMACEUTICALS INCContinue exploring
Similar stocks
FISVFISERV INC334 holders · $21.5B
SPYState Street Spdr S&p 500 Etf Trust TR UNIT294 holders · $348.2B
IVViShares Trust CORE S&P500 ETF262 holders · $566.9B
QQQInvesco QQQ Trust, Series 1 UNIT SER 1246 holders · $125.8B
VOOVanguard Index Funds S&P 500 ETF SHS245 holders · $264.7B
IWMiShares Trust RUSSELL 2000 ETF242 holders · $68.1B
GLDSPDR GOLD SHARES236 holders · $34.1B
XLFSELECT SECTOR SPDR TR224 holders · $31.5B
XLESELECT SECTOR SPDR TR223 holders · $17.3B
EFAiShares Trust MSCI EAFE ETF221 holders · $47.1B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer